Times are changing and payers will have to fall in line, eventually. At this time, we already know that clonal evolution exists but is poorly understood regarding the timeline. However, if we are going to leverage "precision medicine", then to be precise one has to account for clonal evolution in de...

If I have somatic tumor molecular profiling done once, I typically do not repeat. Ideally, it would be nice to repeat to see if there is any change, but practically speaking, I have trouble getting a tumor biopsy paid for if only done for profiling purposes. Also, sometimes there is insurance resist...